Cargando…
Drug Safety and Suicidality Risk of Chronic Pain Medications
Chronic pain is one of the main leading causes of disability in the world at present. A variety in the symptomatology, intensity and duration of this phenomenon has led to an ever-increasing demand of pharmacological treatment and relief. This demand for medication, ranging from well-known groups, s...
Autores principales: | Syed, Osman, Jancic, Predrag, Fink, Adam B., Knezevic, Nebojsa Nick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609967/ https://www.ncbi.nlm.nih.gov/pubmed/37895968 http://dx.doi.org/10.3390/ph16101497 |
Ejemplares similares
-
A Review of Recent Pharmacological Advances in the Management of Diabetes-Associated Peripheral Neuropathy
por: Syed, Osman, et al.
Publicado: (2023) -
The Role of Genetic Polymorphisms in Chronic Pain Patients
por: Knezevic, Nebojsa Nick, et al.
Publicado: (2018) -
The Discrepancy and Agreement between Patient-Reported Percentage Pain Reduction and Calculated Percentage Pain Reduction in Chronic Pain Patients
por: Fink, Adam B., et al.
Publicado: (2023) -
The Role of Kynurenine and Its Metabolites in Comorbid Chronic Pain and Depression
por: Athnaiel, Onella, et al.
Publicado: (2022) -
Glucocorticoid Hormones as Modulators of the Kynurenine Pathway in Chronic Pain Conditions
por: Jovanovic, Filip, et al.
Publicado: (2023)